GASTROINTESTINAL STROMAL NEOPLASM
Clinical trials for GASTROINTESTINAL STROMAL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL NEOPLASM trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough stomach tumors: experimental drug combo enters human testing
Disease control Recruiting nowThis early-stage trial is testing the safety and initial effectiveness of a new oral drug, ziftomenib, when given alongside the standard drug imatinib. It is for adults with advanced gastrointestinal stromal tumors (GIST) whose cancer has continued to grow despite treatment with …
Matched conditions: GASTROINTESTINAL STROMAL NEOPLASM
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists seek tumor samples in hunt for new GIST treatments
Knowledge-focused Recruiting nowThis study aims to follow people with gastrointestinal stromal tumors (GIST) to collect their tumor tissue for laboratory research. Participants will be monitored for up to 10 years and may have surgery at the NIH if needed. The main goal is to use the collected tissue to create …
Matched conditions: GASTROINTESTINAL STROMAL NEOPLASM
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:55 UTC